May. 13 at 12:54 PM
Noble Capital Markets Research Report: SelectQuote (
$SLQT) – Prescription for Profit: Targets Pharmacy Margin Expansion
FY Q3 results. The company reported fiscal Q3 revenue of
$408.2 million, largely in line with our estimate of
$417.0 million. Adj. EBITDA of
$37.7 million was 10% lower than our estimate of
$41.8 million, the variance largely due to higher cost of revenue.
Read more:https://www.channelchek.com/news-channel/selectquote-slqt-prescription-for-profit-targets-pharmacy-margin-expansion